# | ||||
---|---|---|---|---|
1 | INTENTIONS IN ACTION Intentions in Action: Establishing the neural causes of intentional action | 2015 | 171˙460.00 | 171˙460.00 |
2 | TRANSCTNEURODEV Transgenerational transmission of maternal childhood trauma and its sequelae – Altered maternal physiology during pregnancy and implications for newborn neurodevelopment | 2015 | 1˙496˙132.00 | 1˙496˙132.00 |
3 | BRAINMODES Personalized whole brain simulations: linking connectomics and dynamics in the human brain | 2016 | 1˙870˙588.00 | 1˙870˙588.00 |
4 | PRENATSTRESSAGING Prenatal Stress and Programming of Newborn and Infant Telomere Biology and Cellular Aging | 2016 | 1˙483˙720.00 | 1˙483˙720.00 |
5 | PACE A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies | 2017 | 7˙595˙715.00 | 7˙595˙715.00 |
6 | HPSCREG Human Puripotent Stem Cell Registry | 2017 | 1˙000˙000.00 | 1˙000˙000.00 |
7 | DEEPLIGHT Deep imaging with time-reversed light | 2017 | 1˙491˙235.00 | 1˙491˙235.00 |
8 | HIPGEN Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial | 2018 | 7˙437˙127.00 | 7˙437˙127.00 |
9 | PRECISE4Q Personalised Medicine by Predictive Modeling in Stroke for better Quality of Life | 2018 | 5˙978˙245.00 | 5˙978˙245.00 |
10 | NGBMI Building Next-Generation Brain/Neural-Machine Interfaces For Restoration of Brain Functions | 2018 | 1˙498˙125.00 | 1˙498˙125.00 |
11 | VIRTUALBRAINCLOUD Personalized Recommendations for Neurodegenerative Disease | 2018 | 15˙016˙343.00 | 15˙016˙343.00 |
12 | TRUEBRAINCONNECT Advancing the non-invasive assessment of brain communication in neurological disease | 2019 | 1˙499˙875.00 | 1˙499˙875.00 |
13 | RESHAPE Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials | 2019 | 13˙137˙396.00 | 13˙137˙396.00 |
14 | ENDOSCAPE ENDOSCAPE, a clinically applicable non-viral gene delivery technology | 2019 | 6˙850˙643.00 | 6˙850˙643.00 |
15 | EPITUNE Epigenetic fine-tuning of T cells for improved adoptive cell therapy | 2019 | 1˙489˙725.00 | 1˙489˙725.00 |
16 | RESTORE RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients | 2019 | 1˙000˙000.00 | 1˙000˙000.00 |
17 | DDRMAC DNA Damage Response-instructed Macrophage Differentiation in Granulomatous Diseases | 2019 | 1˙500˙000.00 | 1˙500˙000.00 |
18 | MULTIPAN A Multi-omics Approach To Decode Epigenetic Lesions In Pancreatic Cancer Development | 2019 | 162˙806.00 | 162˙806.00 |
19 | ENTRI Enteric-nervous-system-mediated regulation of intestinal inflammation | 2019 | 1˙499˙638.00 | 1˙499˙638.00 |
20 | TCRABX Structural basis for the therapeutic efficiency of optimal-affinity T cell receptors | 2019 | 264˙110.00 | 264˙110.00 |
21 | ESPACE Human Cell Atlas of the Pancreas | 2020 | 4˙962˙494.00 | 4˙962˙494.00 |
22 | HYPERBIOTA Exploring the diet-microbiota axis for immunomodulation and organ protection in hypertension | 2020 | 1˙497˙250.00 | 1˙497˙250.00 |
23 | CLOCK Characterization of the circadian chromatin landscape using a novel CRISPR/Cas9-guided proximity-labelling technique | 2020 | 162˙806.00 | 162˙806.00 |
24 | BATSECOV Canonical and non-canonical secretory mechanisms of cytokines in bat and human cell cultures in response to coronavirus infection: a comparative study | 2021 | 162˙806.00 | 162˙806.00 |
The Institution CHARITE - UNIVERSITAETSMEDIZIN BERLIN has been involved also in the following Horizon 2020 projects.